Agilent Technologies Past Earnings Performance
Past criteria checks 5/6
Agilent Technologies has been growing earnings at an average annual rate of 2.6%, while the Life Sciences industry saw earnings declining at 7% annually. Revenues have been growing at an average rate of 1.8% per year. Agilent Technologies's return on equity is 19.6%, and it has net margins of 19.5%.
Key information
2.60%
Earnings growth rate
4.22%
EPS growth rate
| Life Sciences Industry Growth | 26.83% |
| Revenue growth rate | 1.82% |
| Return on equity | 19.56% |
| Net Margin | 19.53% |
| Last Earnings Update | 31 Jul 2026 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Agilent Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Jul 26 | 7,372 | 1,440 | 1,673 | 473 |
| 30 Apr 26 | 7,232 | 1,414 | 1,598 | 471 |
| 31 Jan 26 | 7,065 | 1,290 | 1,553 | 454 |
| 31 Oct 25 | 6,948 | 1,303 | 1,525 | 450 |
| 31 Jul 25 | 6,788 | 1,220 | 1,561 | 428 |
| 30 Apr 25 | 6,628 | 1,166 | 1,523 | 441 |
| 31 Jan 25 | 6,533 | 1,259 | 1,484 | 445 |
| 31 Oct 24 | 6,510 | 1,289 | 1,478 | 452 |
| 31 Jul 24 | 6,497 | 1,413 | 1,726 | 450 |
| 30 Apr 24 | 6,591 | 1,242 | 1,482 | 459 |
| 31 Jan 24 | 6,735 | 1,236 | 1,515 | 472 |
| 31 Oct 23 | 6,833 | 1,240 | 1,544 | 475 |
| 31 Jul 23 | 6,994 | 1,133 | 1,281 | 486 |
| 30 Apr 23 | 7,040 | 1,351 | 1,579 | 484 |
| 31 Jan 23 | 6,930 | 1,323 | 1,585 | 473 |
| 31 Oct 22 | 6,848 | 1,254 | 1,578 | 467 |
| 31 Jul 22 | 6,659 | 1,328 | 1,552 | 464 |
| 30 Apr 22 | 6,527 | 1,263 | 1,548 | 461 |
| 31 Jan 22 | 6,445 | 1,205 | 1,571 | 455 |
| 31 Oct 21 | 6,319 | 1,210 | 1,562 | 441 |
| 31 Jul 21 | 6,142 | 990 | 1,562 | 426 |
| 30 Apr 21 | 5,817 | 925 | 1,464 | 405 |
| 31 Jan 21 | 5,530 | 810 | 1,404 | 396 |
| 31 Oct 20 | 5,339 | 719 | 1,395 | 397 |
| 31 Jul 20 | 5,223 | 691 | 1,377 | 398 |
| 30 Apr 20 | 5,236 | 683 | 1,446 | 407 |
| 31 Jan 20 | 5,236 | 764 | 1,405 | 406 |
| 31 Oct 19 | 5,163 | 1,071 | 1,358 | 404 |
| 31 Jul 19 | 5,090 | 1,072 | 1,343 | 406 |
| 30 Apr 19 | 5,019 | 1,117 | 1,290 | 402 |
| 31 Jan 19 | 4,987 | 1,140 | 1,301 | 395 |
| 31 Oct 18 | 4,914 | 316 | 1,322 | 387 |
| 31 Jul 18 | 4,809 | 298 | 1,284 | 372 |
| 30 Apr 18 | 4,720 | 237 | 1,269 | 362 |
| 31 Jan 18 | 4,616 | 196 | 1,235 | 354 |
| 31 Oct 17 | 4,472 | 684 | 1,205 | 341 |
| 31 Jul 17 | 4,394 | 633 | 1,173 | 330 |
| 30 Apr 17 | 4,324 | 582 | 1,167 | 329 |
| 31 Jan 17 | 4,241 | 509 | 1,159 | 326 |
| 31 Oct 16 | 4,202 | 462 | 1,174 | 325 |
| 31 Jul 16 | 4,126 | 476 | 1,184 | 324 |
| 30 Apr 16 | 4,096 | 465 | 1,175 | 317 |
| 31 Jan 16 | 4,040 | 466 | 1,170 | 317 |
| 31 Oct 15 | 4,038 | 438 | 1,189 | 327 |
Quality Earnings: AG8 has high quality earnings.
Growing Profit Margin: AG8's current net profit margins (19.5%) are higher than last year (18%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AG8's earnings have grown by 2.6% per year over the past 5 years.
Accelerating Growth: AG8's earnings growth over the past year (18%) exceeds its 5-year average (2.6% per year).
Earnings vs Industry: AG8 earnings growth over the past year (18%) exceeded the Life Sciences industry 17.4%.
Return on Equity
High ROE: AG8's Return on Equity (19.6%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/14 18:40 |
| End of Day Share Price | 2026/09/14 00:00 |
| Earnings | 2026/07/31 |
| Annual Earnings | 2025/10/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Agilent Technologies, Inc. is covered by 39 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Catherine Ramsey Schulte | Baird |
| Robert Bamberger | Baird |
| Charles Butler | Barclays |